October 2018 | Bonus Feature
Systemic Options for Treating Uveitis
Biologics is the name of the game. Here's a peek at what's been approved and what may be soon to come.
Sruthi Arepalli, MD, and Eric B. Suhler, MD, MPH
September 2018 | Bonus Feature
Gas Bubbles and Altitude
“Classical Gas” meets “Rocky Mountain High” and “Leaving on a Jet Plane.”
Brian C. Joondeph, MD, MPS
May/June 2018 | Bonus Feature
The 4-1-1 on Infectious Retinitis
Challenges in the diagnosis and management of fungal endophthalmitis.
Alice Y. Zhang, MD, and Ashvini K. Reddy, MD
April 2018 | Bonus Feature
First Gene Therapy FDA-Approved for an Inherited Retinal Disease
The approval has stimulated research into gene therapies for other IRDs.
Meghan J. DeBenedictis, MS, LGC, MEd, and Aleksandra V. Rachitskaya, MD
November/December 2017 | Bonus Feature
The Latest Data on Anti-Integrin Therapy for Patients With DME
In a phase 2b study, ALG-1001 showed additional efficacy in patients who had plateaued on chronic anti-VEGF therapy.
Peter K. Kaiser, MD